Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patientsJ Taieb, R Balogoun, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancerJ Grasselli, E Elez, G Caratù, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, S A Im, et al.
ESMO Open|April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoringB Gyawali, E G E de Vries, U Dafni, et al.
ESMO Open|December 20, 2021
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studiesA S Berghoff, C Sessa, J C-H Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III studyT Yoshino, D C Portnoy, R Obermannová, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2018
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)A Marabelle, R Andtbacka, K Harrington, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
European Journal of Radiology|July 1, 2026
Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancerKate Connor, Olivia Prior, Liam P Shiels, et al.
Pageof 18